Janux Therapeutics, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2025-06-30
Reported
2025-08-07
Disclosure lag
38 days

Context

links are based on the recorded entity type
FieldRecorded value
EntityJanux Therapeutics, Inc.
SourceSEC EDGAR
Source identifiercompanyfacts/CIK0001817713/2026-07-26
Event ID#29433

Recorded payload

JSON payload as stored after parsing
{
  "accession": "0000950170-25-105069",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "Q2",
  "fiscal_year": 2025,
  "form": "10-Q",
  "mapped_tag_share": 0.05963302752293578,
  "metrics": {
    "cash_and_equivalents": 52446000,
    "earnings_per_share_basic": -0.55,
    "earnings_per_share_diluted": -0.55,
    "net_income": -33858000,
    "operating_income": -45118000,
    "revenue": 0,
    "shareholders_equity": 990516000,
    "shares_outstanding": 59297814,
    "total_assets": 1032212000,
    "total_liabilities": 41696000
  },
  "metrics_reported": 10,
  "period_end": "2025-06-30"
}

Source: SEC EDGAR · as of 2025-08-07T00:00:00Z

Janux Therapeutics, Inc. — recorded event — Tapewire